Health ❯ Healthcare ❯ Clinical Trials

Pharmaceuticals

Weight Loss Azelastine Antibody-Drug Conjugates Cancer Treatment Galectin-1 Inhibitor OTX008 Orforglipron Drug Development Aficamten Combination Therapy NervGen Pharma GLP-1 Agonists Anti-Obesity Treatments Liraglutide Daratumumab Gene Therapy Development Oral Therapies Semaglutide Epilepsy Menin Inhibitors Cancer Therapies Weight Loss Drugs

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

The miss triggered target cuts alongside a securities investigation into prior comments.

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma